Response to vitamin D replacement in overweight and normal weight children with vitamin D deficiency
- PMID: 30943676
- PMCID: PMC6449617
- DOI: 10.6065/apem.2019.24.1.22
Response to vitamin D replacement in overweight and normal weight children with vitamin D deficiency
Abstract
Purpose: It is well known that obesity is related to vitamin D deficiency (VDD). We investigated the response to vitamin D replacement in normal-weight and overweight children.
Methods: This was a prospective study including 62 Korean children with VDD. VDD was defined as a serum 25-hydroxycholecalciferol (25(OH)D) concentration <20 ng/mL. Overweight was defined as a body mass index (BMI)≥the 85th percentile (n=21), and normal weight as a BMI between the 5th and 84th percentiles (n=41). All participants received vitamin D3 supplementation (2,000 IU/day) for 8 weeks. The serum levels of 25(OH)D, PTH and biochemical parameters were measured before and after treatment.
Results: The mean age was 10.0±1.4 years in normal-weight children and 10.0±2.1 years in overweight children (P=0.93). After 8 weeks of treatment, 61.9% of normal-weight children and 47.6% of overweight children achieved vitamin D sufficiency (P =0.30). The mean serum 25(OH)D levels after vitamin D replacement were 33.8±7.6 ng/mL and 30.3±6.6 ng/mL in normal-weight and overweight children, respectively (P =0.10). The mean calcium/creatinine ratios after treatment were 0.09±0.07 and 0.08±0.06 in the normal-weight and overweight groups, respectively, and no hypercalciuria was found. In multiple regression analysis, the response to vitamin D replacement was influenced by the BMI (β=-1.0, P=0.03) and sex (β=-4.0, P=0.04).
Conclusion: Eight weeks of vitamin D replacement (2,000 IU/day) is sufficient to overcome vitamin D deficiency in normal-weight and overweight children without any complications.
Keywords: Child; Obesity; Overweight; Supplement; Vitamin D.
Figures
Similar articles
-
Vitamin D deficiency in Korean children: prevalence, risk factors, and the relationship with parathyroid hormone levels.Ann Pediatr Endocrinol Metab. 2014 Jun;19(2):86-90. doi: 10.6065/apem.2014.19.2.86. Epub 2014 Jun 30. Ann Pediatr Endocrinol Metab. 2014. PMID: 25077091 Free PMC article.
-
Impact of three different daily doses of vitamin D3 supplementation in healthy schoolchildren and adolescents from North India: a single-blind prospective randomised clinical trial.Br J Nutr. 2019 Mar;121(5):538-548. doi: 10.1017/S0007114518003690. Br J Nutr. 2019. PMID: 30843501 Clinical Trial.
-
25-Hydroxycholecalciferol response to single oral cholecalciferol loading in the normal weight, overweight, and obese.Osteoporos Int. 2016 Aug;27(8):2593-602. doi: 10.1007/s00198-016-3574-y. Epub 2016 Mar 30. Osteoporos Int. 2016. PMID: 27026331
-
Effect of vitamin D3 seasonal supplementation with 1500 IU/day in north Italian children (DINOS study).Ital J Pediatr. 2019 Jan 28;45(1):18. doi: 10.1186/s13052-018-0590-x. Ital J Pediatr. 2019. PMID: 30691521 Free PMC article.
-
The Prevalence of Vitamin D Deficiency in Patients Undergoing Total Knee Arthroplasty: A Propensity Score Matching Analysis.Arch Osteoporos. 2022 Mar 23;17(1):53. doi: 10.1007/s11657-022-01097-7. Arch Osteoporos. 2022. PMID: 35320426 Free PMC article.
Cited by
-
Commentary on "Low serum 25-hydroxyvitamin D level is associated with obesity and atherogenesis in adolescent boys".Ann Pediatr Endocrinol Metab. 2022 Mar;27(1):3-4. doi: 10.6065/apem.2221056edi01. Epub 2022 Mar 31. Ann Pediatr Endocrinol Metab. 2022. PMID: 35368190 Free PMC article. No abstract available.
References
-
- DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(6 Suppl):1689S–1696S. - PubMed
-
- Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81. - PubMed
-
- Jorde R, Sneve M, Emaus N, Figenschau Y, Grimnes G. Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study. Eur J Nutr. 2010;49:401–7. - PubMed
LinkOut - more resources
Full Text Sources